Federal Trade Commission accuses three drug middlemen of inflating insulin prices
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated ...
Drug Overdose Deaths Are Dropping. The Reasons Are Not Perfectly Clear.
The decrease across the country is a major breakthrough in efforts to reverse the effects of fentanyl. Researchers and health ...
An appeals court has revived a challenge to President Biden's Medicare drug price reduction program
A constitutional challenge to the Biden administration program enabling Medicare to negotiate lower prices for prescription drugs has been revived by a federal appeals court ...
STAT2d
Novo’s new obesity drug shows modest results, raises concerns of psychiatric side effects
A next-generation obesity drug candidate from Novo Nordisk produced modest weight loss, along with a higher rate of some ...
Challenge to US drug price negotiation program revived by appeals court
A U.S. appeals court revived a lawsuit on Friday by healthcare and drug industry groups challenging the first-ever U.S. law ...
F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices
The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive ...
Targeted Oncology2d
FDA Clears Investigational New Drug Application for CD-001 in Oncology
Following an investigational new drug application clearance from the FDA, a phase 1 trial plans to evaluate CD-001.
Medscape2d
Elinzanetant Shows Significant Improvement in Menopausal Vasomotor and Sleep Symptoms
Targeting two receptors instead of the one targeted by fezolinetant, the new elinzanetant did not show the liver safety ...
SciSparc Takes Major Step Forward with IND Application submitted to the FDA for Phase IIb Clinical Trial for Tourette Syndrome Treatment
Yale Child Study Center at the Yale School of Medicine in the USA, Hannover Medical School in Germany and Tel Aviv Sourasky Medical Center in ...
Advanced drug screening: A microphysiological system to assess drug transport and nephrotoxicity
Developing advanced drug screening tools is crucial for the advancement of personalized medicine and the creation of more ...
News Medical5d
Ohio State's novel DHODH inhibitor enters first human trials
A new therapeutic agent discovered and developed at The Ohio State University will soon be used for cancer treatment at the patient's bedside as part of a clinical trial.
GlobalData on MSN5d
FDA grants RMAT to Poseida’s CAR-T cell therapy P-BCMA-ALLO1
The therapy is currently in Phase I/Ib clinical development for patients with relapsed/refractory multiple myeloma.